Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
US Department of Justice
Fish and Richardson
Argus Health

Generated: February 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 208424

« Back to Dashboard

NDA 208424 describes GONITRO, which is a drug marketed by Pohl Boskamp and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the GONITRO profile page.

The generic ingredient in GONITRO is nitroglycerin. There are thirty-six drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.
Summary for 208424
Applicant:Pohl Boskamp
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 208424
Physiological EffectVasodilation
Medical Subject Heading (MeSH) Categories for 208424
Suppliers and Packaging for NDA: 208424
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
GONITRO nitroglycerin POWDER;SUBLINGUAL 208424 NDA Espero Pharmaceuticals, Inc. 70007-400 N 70007-400-12
GONITRO nitroglycerin POWDER;SUBLINGUAL 208424 NDA Espero Pharmaceuticals, Inc. 70007-400 N 70007-400-36

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;SUBLINGUALStrength0.4MG/PACKET
Approval Date:Jun 8, 2016TE:RLD:Yes
Patent:➤ Sign UpPatent Expiration:Mar 11, 2032Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.